BUZZ-Lantheus climbs on Curium's up to $8 bln buyout offer

Shares of radiopharmaceutical-focused company Lantheus Holdings LNTH.O rose 3.1% to $102.69 in premarket trading.

Curium agreed to acquire Lantheus in a deal worth up to $8 billion.

Lantheus shareholders would receive $102.50 per share in cash at closing and could receive up to $12 more per share if certain sales milestones are met.

The total consideration of up to $114.50 per share represents a premium of about 14.9% to Lantheus stock's last closing price of $99.64.

The combined company is expected to serve patients in more than 70 countries, and the transaction is expected to close in the first half of 2027.

As of the last close, LNTH was up 49.7% year to date.